Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C21H26N2O |
| Molecular Weight | 322.4439 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CC=CC=C1N2CCN(CC2)C3CCC4=C(C3)C=CC(O)=C4
InChI
InChIKey=ZYGBSDBJSDMKLV-UHFFFAOYSA-N
InChI=1S/C21H26N2O/c1-16-4-2-3-5-21(16)23-12-10-22(11-13-23)19-8-6-18-15-20(24)9-7-17(18)14-19/h2-5,7,9,15,19,24H,6,8,10-14H2,1H3
Tolnapersine is an antihypertensive drug. It is a compound with mixed dopamine agonist and alpha-adrenoceptor antagonist activity. Tolnapersine at a dose of 50 mg resulted in a fall in mean blood pressure. Tolnapersine at the higher dose produced a significant tachycardia, which would be compatible with a compensatory response to vasodilation. Also, at the higher dose tolnapersine produces sedation. Many compounds have been reported as potential reversing agents of multidrug resistance. Tolnapersine yielded a good activity (ratio of > 10).
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3841005
50 and 100 mg
Route of Administration:
Oral
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C270
Created by
admin on Wed Apr 02 06:53:39 GMT 2025 , Edited by admin on Wed Apr 02 06:53:39 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
5377
Created by
admin on Wed Apr 02 06:53:39 GMT 2025 , Edited by admin on Wed Apr 02 06:53:39 GMT 2025
|
PRIMARY | |||
|
757872
Created by
admin on Wed Apr 02 06:53:39 GMT 2025 , Edited by admin on Wed Apr 02 06:53:39 GMT 2025
|
PRIMARY | |||
|
100000077778
Created by
admin on Wed Apr 02 06:53:39 GMT 2025 , Edited by admin on Wed Apr 02 06:53:39 GMT 2025
|
PRIMARY | |||
|
C152685
Created by
admin on Wed Apr 02 06:53:39 GMT 2025 , Edited by admin on Wed Apr 02 06:53:39 GMT 2025
|
PRIMARY | |||
|
68893
Created by
admin on Wed Apr 02 06:53:39 GMT 2025 , Edited by admin on Wed Apr 02 06:53:39 GMT 2025
|
PRIMARY | |||
|
CHEMBL2105564
Created by
admin on Wed Apr 02 06:53:39 GMT 2025 , Edited by admin on Wed Apr 02 06:53:39 GMT 2025
|
PRIMARY | |||
|
DTXSID40867917
Created by
admin on Wed Apr 02 06:53:39 GMT 2025 , Edited by admin on Wed Apr 02 06:53:39 GMT 2025
|
PRIMARY | |||
|
70312-00-4
Created by
admin on Wed Apr 02 06:53:39 GMT 2025 , Edited by admin on Wed Apr 02 06:53:39 GMT 2025
|
PRIMARY | |||
|
SUB11164MIG
Created by
admin on Wed Apr 02 06:53:39 GMT 2025 , Edited by admin on Wed Apr 02 06:53:39 GMT 2025
|
PRIMARY | |||
|
72MZZ4V9KL
Created by
admin on Wed Apr 02 06:53:39 GMT 2025 , Edited by admin on Wed Apr 02 06:53:39 GMT 2025
|
PRIMARY |
ACTIVE MOIETY